ONCONETIX INC (ONCO)

US09610B1089 - Common Stock

0.156  -0.01 (-6.7%)

News Image
4 days ago - Chartmill

Let's take a look at the stocks that are in motion in today's session.

Which stocks are experiencing notable movement on Thursday?

News Image
13 days ago - Chartmill

Top movers in Tuesday's pre-market session

Get insights into the top gainers and losers of Tuesday's pre-market session.

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!

News Image
a month ago - InvestorPlace

ONCO Stock Earnings: Onconetix Reported Results for Q1 2024

Onconetix just reported results for the first quarter of 2024.

News Image
5 months ago - Onconetix, Inc.

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

CINCINNATI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) (

News Image
5 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic on Thursday morning and we have all the coverage traders need to know about today.

News Image
2 years ago - Oncopeptides AB

Oncopeptides provides an update from the meeting with FDAs advisory committee ODAC

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for...

News Image
2 years ago - Oncopeptides AB

Briefing Book for ODAC meeting on benefit/risk profile of Pepaxto now published

/PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for...